Immunovant (IMVT) Operating Leases (2020 - 2023)
Immunovant's Operating Leases came in at $47,000 for fiscal Q4 2023 (quarter ended Mar 31, 2023), down 96.1% from $1.22 million a year earlier and down 84.6% from the prior quarter.
Powered by 
Analysis
Immunovant (IMVT) Operating Leases (2020 - 2023) Analysis & Trends
Going back to fiscal Q1 2021, Immunovant's Operating Leases data covers 12 quarters.
- Going back by fiscal year, Operating Leases was $1.22 million in FY2022 (-45.5%) and $2.24 million in FY2021.
- The fiscal Q4 2023 figure represents the lowest quarterly Operating Leases in data going back to fiscal Q1 2021.
- Year-over-year, Operating Leases has declined for eight consecutive quarters, with an average decline of 54.5% over the last eight quarters.
- The year-over-year decline in Operating Leases has ranged between 27.1% (fiscal Q2 2022) and 96.1% (fiscal Q4 2023) over the last five years.
- Business Quant data shows IMVT's Operating Leases at $306,000 (Q3 2023), $614,000 (Q2 2023) and $919,000 (Q1 2023) in the three fiscal quarters before Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Immunovant | 6.91 Bn | 6.91 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 47,000.00 |
| Dec 31, 2022 | 306,000.00 |
| Sep 30, 2022 | 614,000.00 |
| Jun 30, 2022 | 919,000.00 |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 1.68 Mn |
| Sep 30, 2021 | 1.95 Mn |
| Jun 30, 2021 | 1.97 Mn |
| Mar 31, 2021 | 2.24 Mn |
| Dec 31, 2020 | 2.39 Mn |
| Sep 30, 2020 | 2.68 Mn |
| Jun 30, 2020 | 2.97 Mn |
API Access
Immunovant Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();